In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
November 21st, 2005 | 17 | Yes |
Popular Name: Dibenzo[cd,g]indazol-6(2H)-one Dibenzo[cd,g]indazol-6(2H)-one
Find On: PubMed — Wikipedia — Google
CAS Numbers: 129-56-6 , [129-56-6]
1,6-dihydrodibenzo[cd,g]indazol-6-one
2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.48 | 6.16 | -10.65 | 1 | 3 | 0 | 46 | 220.231 | 0 | ↓ |
Mid Mid (pH 6-8) | 3.49 | 4.15 | -24.93 | 1 | 3 | 0 | 46 | 220.231 | 0 | ↓ |
Mid Mid (pH 6-8) | 3.48 | 6.17 | -10.96 | 1 | 3 | 0 | 46 | 220.231 | 0 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
biological_use | Antineoplastic agent | ZereneX Building Blocks |
ALOGPS_SOLUBILITY | 1.86e-01 g/l | DrugBank-experimental |
MP | 236 - 238 | Enamine Building Blocks |
MP | 236...238 | Enamine Building Blocks |
MP | 279 - 281 | Enamine Building Blocks |
purity | 9.500000000000000e+001 | Enamine Building Blocks Enamine Building Blocks |
Purity | >98% | Fluorochem |
biological_use | Antineoplastic agent | IBScreen Bioactives |
Target | JNK | Selleck Chemicals |
Therapy | Kinase inhibitors: JNK inhibitor | SMDC Life Kinase |
mechanism | Selective c-Jun N-terminal kinase (JNK) inhibitor | IBScreen Bioactives |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
AAK1-2-E | Adaptor-associated Kinase (cluster #2 Of 2), Eukaryotic | Eukaryotes | 35 | 0.61 | Binding ≤ 10μM |
AURKA-2-E | Serine/threonine-protein Kinase Aurora-A (cluster #2 Of 3), Eukaryotic | Eukaryotes | 980 | 0.49 | Binding ≤ 10μM |
AURKC-2-E | Serine/threonine-protein Kinase Aurora-C (cluster #2 Of 2), Eukaryotic | Eukaryotes | 5300 | 0.43 | Binding ≤ 10μM |
BMP2K-2-E | BMP-2-inducible Protein Kinase (cluster #2 Of 2), Eukaryotic | Eukaryotes | 25 | 0.63 | Binding ≤ 10μM |
CDK16-1-E | Serine/threonine-protein Kinase PCTAIRE-1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 180 | 0.56 | Binding ≤ 10μM |
CDK2-5-E | Cyclin-dependent Kinase 2 (cluster #5 Of 5), Eukaryotic | Eukaryotes | 3200 | 0.45 | Binding ≤ 10μM |
CLK2-2-E | Dual Specificity Protein Kinase CLK2 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 300 | 0.54 | Binding ≤ 10μM |
CLK4-2-E | Dual Specificity Protein Kinase CLK4 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 260 | 0.54 | Binding ≤ 10μM |
DAPK2-2-E | Death-associated Protein Kinase 2 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 610 | 0.51 | Binding ≤ 10μM |
DAPK3-2-E | Death-associated Protein Kinase 3 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 410 | 0.53 | Binding ≤ 10μM |
E2AK2-1-E | Interferon-induced, Double-stranded RNA-activated Protein Kinase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 8000 | 0.42 | Binding ≤ 10μM |
EPHA3-2-E | Ephrin Type-A Receptor 3 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 4000 | 0.44 | Binding ≤ 10μM |
GAK-2-E | Serine/threonine-protein Kinase GAK (cluster #2 Of 2), Eukaryotic | Eukaryotes | 38 | 0.61 | Binding ≤ 10μM |
JAK3-2-E | Tyrosine-protein Kinase JAK3 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 957 | 0.50 | Binding ≤ 10μM |
KC1E-2-E | Casein Kinase I Epsilon (cluster #2 Of 2), Eukaryotic | Eukaryotes | 3100 | 0.45 | Binding ≤ 10μM |
KC1G1-2-E | Casein Kinase I Gamma 1 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 3700 | 0.45 | Binding ≤ 10μM |
KCC1A-2-E | CaM Kinase I Alpha (cluster #2 Of 2), Eukaryotic | Eukaryotes | 4100 | 0.44 | Binding ≤ 10μM |
KCC1D-2-E | CaM Kinase I Delta (cluster #2 Of 2), Eukaryotic | Eukaryotes | 1400 | 0.48 | Binding ≤ 10μM |
KCC1G-2-E | CaM Kinase I Gamma (cluster #2 Of 2), Eukaryotic | Eukaryotes | 4200 | 0.44 | Binding ≤ 10μM |
KKCC2-2-E | CaM-kinase Kinase Beta (cluster #2 Of 2), Eukaryotic | Eukaryotes | 7500 | 0.42 | Binding ≤ 10μM |
KS6A2-2-E | Ribosomal Protein S6 Kinase Alpha 2 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 2200 | 0.47 | Binding ≤ 10μM |
KS6A5-1-E | Ribosomal Protein S6 Kinase Alpha 5 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 1700 | 0.48 | Binding ≤ 10μM |
MARK2-2-E | MAP/microtubule Affinity-regulating Kinase 2 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 1800 | 0.47 | Binding ≤ 10μM |
MK08-5-E | Mitogen-activated Protein Kinase 8 (cluster #5 Of 5), Eukaryotic | Eukaryotes | 40 | 0.61 | Binding ≤ 10μM |
MK09-3-E | C-Jun N-terminal Kinase 2 (cluster #3 Of 3), Eukaryotic | Eukaryotes | 84 | 0.58 | Binding ≤ 10μM |
MK10-2-E | C-Jun N-terminal Kinase 3 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 90 | 0.58 | Binding ≤ 10μM |
MK12-2-E | MAP Kinase P38 Gamma (cluster #2 Of 2), Eukaryotic | Eukaryotes | 2400 | 0.46 | Binding ≤ 10μM |
MKNK2-2-E | MAP Kinase Signal-integrating Kinase 2 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 1000 | 0.49 | Binding ≤ 10μM |
PHKG2-2-E | Phosphorylase Kinase Gamma Subunit 2 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 480 | 0.52 | Binding ≤ 10μM |
PIM2-2-E | Serine/threonine-protein Kinase PIM2 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 460 | 0.52 | Binding ≤ 10μM |
PLK4-1-E | Serine/threonine-protein Kinase PLK4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 770 | 0.50 | Binding ≤ 10μM |
SLK-2-E | Serine/threonine-protein Kinase 2 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 2300 | 0.46 | Binding ≤ 10μM |
ST17A-2-E | Serine/threonine-protein Kinase 17A (cluster #2 Of 2), Eukaryotic | Eukaryotes | 2100 | 0.47 | Binding ≤ 10μM |
ST38L-2-E | Serine/threonine-protein Kinase 38-like (cluster #2 Of 2), Eukaryotic | Eukaryotes | 2300 | 0.46 | Binding ≤ 10μM |
STK16-1-E | Serine/threonine-protein Kinase 16 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 510 | 0.52 | Binding ≤ 10μM |
STK3-2-E | Serine/threonine-protein Kinase MST2 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 220 | 0.55 | Binding ≤ 10μM |
STK4-2-E | Serine/threonine-protein Kinase MST1 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 2200 | 0.47 | Binding ≤ 10μM |
TNIK-2-E | TRAF2- And NCK-interacting Kinase (cluster #2 Of 2), Eukaryotic | Eukaryotes | 480 | 0.52 | Binding ≤ 10μM |
TTK-2-E | Dual Specificity Protein Kinase TTK (cluster #2 Of 2), Eukaryotic | Eukaryotes | 98 | 0.58 | Binding ≤ 10μM |
ULK3-2-E | Serine/threonine-protein Kinase ULK3 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 680 | 0.51 | Binding ≤ 10μM |
Z50425-3-O | Plasmodium Falciparum (cluster #3 Of 22), Other | Other | 7943 | 0.42 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
AAK1_HUMAN | Q2M2I8 | Adaptor-associated Kinase, Human | 35 | 0.61 | Binding ≤ 1μM |
BMP2K_HUMAN | Q9NSY1 | BMP-2-inducible Protein Kinase, Human | 25 | 0.63 | Binding ≤ 1μM |
MK08_HUMAN | P45983 | C-Jun N-terminal Kinase 1, Human | 100 | 0.58 | Binding ≤ 1μM |
MK09_HUMAN | P45984 | C-Jun N-terminal Kinase 2, Human | 40 | 0.61 | Binding ≤ 1μM |
MK10_HUMAN | P53779 | C-Jun N-terminal Kinase 3, Human | 22 | 0.63 | Binding ≤ 1μM |
DAPK2_HUMAN | Q9UIK4 | Death-associated Protein Kinase 2, Human | 610 | 0.51 | Binding ≤ 1μM |
DAPK3_HUMAN | O43293 | Death-associated Protein Kinase 3, Human | 410 | 0.53 | Binding ≤ 1μM |
CLK2_HUMAN | P49760 | Dual Specificity Protein Kinase CLK2, Human | 300 | 0.54 | Binding ≤ 1μM |
CLK4_HUMAN | Q9HAZ1 | Dual Specificity Protein Kinase CLK4, Human | 260 | 0.54 | Binding ≤ 1μM |
TTK_HUMAN | P33981 | Dual Specificity Protein Kinase TTK, Human | 98 | 0.58 | Binding ≤ 1μM |
MKNK2_HUMAN | Q9HBH9 | MAP Kinase Signal-integrating Kinase 2, Human | 1000 | 0.49 | Binding ≤ 1μM |
PHKG2_HUMAN | P15735 | Phosphorylase Kinase Gamma Subunit 2, Human | 480 | 0.52 | Binding ≤ 1μM |
STK16_HUMAN | O75716 | Serine/threonine-protein Kinase 16, Human | 510 | 0.52 | Binding ≤ 1μM |
AURKA_HUMAN | O14965 | Serine/threonine-protein Kinase Aurora-A, Human | 980 | 0.49 | Binding ≤ 1μM |
GAK_HUMAN | O14976 | Serine/threonine-protein Kinase GAK, Human | 38 | 0.61 | Binding ≤ 1μM |
STK3_MOUSE | Q9JI10 | Serine/threonine-protein Kinase MST2, Mouse | 220 | 0.55 | Binding ≤ 1μM |
CDK16_HUMAN | Q00536 | Serine/threonine-protein Kinase PCTAIRE-1, Human | 180 | 0.56 | Binding ≤ 1μM |
PIM2_HUMAN | Q9P1W9 | Serine/threonine-protein Kinase PIM2, Human | 460 | 0.52 | Binding ≤ 1μM |
PLK4_HUMAN | O00444 | Serine/threonine-protein Kinase PLK4, Human | 770 | 0.50 | Binding ≤ 1μM |
TNIK_HUMAN | Q9UKE5 | TRAF2- And NCK-interacting Kinase, Human | 480 | 0.52 | Binding ≤ 1μM |
JAK3_HUMAN | P52333 | Tyrosine-protein Kinase JAK3, Human | 957 | 0.50 | Binding ≤ 1μM |
ULK3_MOUSE | Q3U3Q1 | ULK3 Kinase, Mouse | 680 | 0.51 | Binding ≤ 1μM |
AAK1_HUMAN | Q2M2I8 | Adaptor-associated Kinase, Human | 35 | 0.61 | Binding ≤ 10μM |
BMP2K_HUMAN | Q9NSY1 | BMP-2-inducible Protein Kinase, Human | 25 | 0.63 | Binding ≤ 10μM |
MK08_HUMAN | P45983 | C-Jun N-terminal Kinase 1, Human | 100 | 0.58 | Binding ≤ 10μM |
MK09_HUMAN | P45984 | C-Jun N-terminal Kinase 2, Human | 40 | 0.61 | Binding ≤ 10μM |
MK10_HUMAN | P53779 | C-Jun N-terminal Kinase 3, Human | 22 | 0.63 | Binding ≤ 10μM |
KCC1A_HUMAN | Q14012 | CaM Kinase I Alpha, Human | 4100 | 0.44 | Binding ≤ 10μM |
KCC1D_HUMAN | Q8IU85 | CaM Kinase I Delta, Human | 1400 | 0.48 | Binding ≤ 10μM |
KCC1G_HUMAN | Q96NX5 | CaM Kinase I Gamma, Human | 4200 | 0.44 | Binding ≤ 10μM |
KKCC2_HUMAN | Q96RR4 | CaM-kinase Kinase Beta, Human | 7500 | 0.42 | Binding ≤ 10μM |
KC1E_HUMAN | P49674 | Casein Kinase I Epsilon, Human | 3100 | 0.45 | Binding ≤ 10μM |
KC1G1_HUMAN | Q9HCP0 | Casein Kinase I Gamma 1, Human | 3700 | 0.45 | Binding ≤ 10μM |
CDK2_HUMAN | P24941 | Cyclin-dependent Kinase 2, Human | 3200 | 0.45 | Binding ≤ 10μM |
DAPK2_HUMAN | Q9UIK4 | Death-associated Protein Kinase 2, Human | 610 | 0.51 | Binding ≤ 10μM |
DAPK3_HUMAN | O43293 | Death-associated Protein Kinase 3, Human | 410 | 0.53 | Binding ≤ 10μM |
CLK2_HUMAN | P49760 | Dual Specificity Protein Kinase CLK2, Human | 300 | 0.54 | Binding ≤ 10μM |
CLK4_HUMAN | Q9HAZ1 | Dual Specificity Protein Kinase CLK4, Human | 260 | 0.54 | Binding ≤ 10μM |
TTK_HUMAN | P33981 | Dual Specificity Protein Kinase TTK, Human | 98 | 0.58 | Binding ≤ 10μM |
EPHA3_HUMAN | P29320 | Ephrin Type-A Receptor 3, Human | 4000 | 0.44 | Binding ≤ 10μM |
E2AK2_HUMAN | P19525 | Interferon-induced, Double-stranded RNA-activated Protein Kinase, Human | 8000 | 0.42 | Binding ≤ 10μM |
MK12_HUMAN | P53778 | MAP Kinase P38 Gamma, Human | 2400 | 0.46 | Binding ≤ 10μM |
MKNK2_HUMAN | Q9HBH9 | MAP Kinase Signal-integrating Kinase 2, Human | 1000 | 0.49 | Binding ≤ 10μM |
MARK2_HUMAN | Q7KZI7 | MAP/microtubule Affinity-regulating Kinase 2, Human | 1800 | 0.47 | Binding ≤ 10μM |
PHKG2_HUMAN | P15735 | Phosphorylase Kinase Gamma Subunit 2, Human | 480 | 0.52 | Binding ≤ 10μM |
KS6A2_HUMAN | Q15349 | Ribosomal Protein S6 Kinase Alpha 2, Human | 2200 | 0.47 | Binding ≤ 10μM |
KS6A5_HUMAN | O75582 | Ribosomal Protein S6 Kinase Alpha 5, Human | 1700 | 0.48 | Binding ≤ 10μM |
STK16_HUMAN | O75716 | Serine/threonine-protein Kinase 16, Human | 510 | 0.52 | Binding ≤ 10μM |
ST17A_HUMAN | Q9UEE5 | Serine/threonine-protein Kinase 17A, Human | 2100 | 0.47 | Binding ≤ 10μM |
SLK_HUMAN | Q9H2G2 | Serine/threonine-protein Kinase 2, Human | 2300 | 0.46 | Binding ≤ 10μM |
ST38L_HUMAN | Q9Y2H1 | Serine/threonine-protein Kinase 38-like, Human | 2300 | 0.46 | Binding ≤ 10μM |
AURKA_HUMAN | O14965 | Serine/threonine-protein Kinase Aurora-A, Human | 980 | 0.49 | Binding ≤ 10μM |
AURKC_HUMAN | Q9UQB9 | Serine/threonine-protein Kinase Aurora-C, Human | 5300 | 0.43 | Binding ≤ 10μM |
GAK_HUMAN | O14976 | Serine/threonine-protein Kinase GAK, Human | 38 | 0.61 | Binding ≤ 10μM |
STK4_HUMAN | Q13043 | Serine/threonine-protein Kinase MST1, Human | 2200 | 0.47 | Binding ≤ 10μM |
STK3_MOUSE | Q9JI10 | Serine/threonine-protein Kinase MST2, Mouse | 220 | 0.55 | Binding ≤ 10μM |
CDK16_HUMAN | Q00536 | Serine/threonine-protein Kinase PCTAIRE-1, Human | 180 | 0.56 | Binding ≤ 10μM |
PIM2_HUMAN | Q9P1W9 | Serine/threonine-protein Kinase PIM2, Human | 460 | 0.52 | Binding ≤ 10μM |
PLK4_HUMAN | O00444 | Serine/threonine-protein Kinase PLK4, Human | 770 | 0.50 | Binding ≤ 10μM |
TNIK_HUMAN | Q9UKE5 | TRAF2- And NCK-interacting Kinase, Human | 480 | 0.52 | Binding ≤ 10μM |
JAK3_HUMAN | P52333 | Tyrosine-protein Kinase JAK3, Human | 957 | 0.50 | Binding ≤ 10μM |
ULK3_MOUSE | Q3U3Q1 | ULK3 Kinase, Mouse | 680 | 0.51 | Binding ≤ 10μM |
Z50425 | Z50425 | Plasmodium Falciparum | 7943.28235 | 0.42 | Functional ≤ 10μM |
Description | Species |
---|---|
Activation of ATR in response to replication stress | |
Activation of BIM and translocation to mitochondria | |
Activation of BMF and translocation to mitochondria | |
Activation of PPARGC1A (PGC-1alpha) by phosphorylation | |
Activation of the AP-1 family of transcription factors | |
Activation of the pre-replicative complex | |
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins | |
CDK-mediated phosphorylation and removal of Cdc6 | |
CDO in myogenesis | |
Circadian Clock | |
CREB phosphorylation | |
CREB phosphorylation through the activation of Ras | |
Cyclin A/B1 associated events during G2/M transition | |
Cyclin A:Cdk2-associated events at S phase entry | |
Cyclin E associated events during G1/S transition | |
DNA Damage/Telomere Stress Induced Senescence | |
DSCAM interactions | |
EPH-ephrin mediated repulsion of cells | |
EPH-Ephrin signaling | |
EPHA-mediated growth cone collapse | |
ERK/MAPK targets | |
Factors involved in megakaryocyte development and platelet production | |
FCERI mediated MAPK activation | |
G0 and Early G1 | |
G2 Phase | |
Gastrin-CREB signalling pathway via PKC and MAPK | |
Glycogen breakdown (glycogenolysis) | |
Golgi Associated Vesicle Biogenesis | |
Inhibition of PKR | |
Interleukin receptor SHC signaling | |
Interleukin-2 signaling | |
Interleukin-7 signaling | |
ISG15 antiviral mechanism | |
JNK (c-Jun kinases) phosphorylation and activation mediated by activated human | |
Loss of Nlp from mitotic centrosomes | |
Loss of proteins required for interphase microtubule organization from the ce | |
Meiotic recombination | |
NCAM signaling for neurite out-growth | |
NOD1/2 Signaling Pathway | |
NRAGE signals death through JNK | |
NRIF signals cell death from the nucleus | |
Orc1 removal from chromatin | |
Oxidative Stress Induced Senescence | |
p38MAPK events | |
p53-Dependent G1 DNA Damage Response | |
Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 | |
Recruitment of mitotic centrosome proteins and complexes | |
Recycling pathway of L1 | |
Regulation of APC/C activators between G1/S and early anaphase | |
Regulation of PLK1 Activity at G2/M Transition | |
Role of DCC in regulating apoptosis | |
RSK activation | |
SCF(Skp2)-mediated degradation of p27/p21 | |
Senescence-Associated Secretory Phenotype (SASP) | |
Signaling by Hippo | |
VEGFA-VEGFR2 Pathway | |
WNT mediated activation of DVL |
No pre-computed analogs available. Try a structural similarity search.